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Abstract
Background: The C57BL/6J.YA/J mouse strain is a chromosome-substituted line where the original male-specific
portion of chromosome Y (MSY) from C57BL/6J mice was substituted for that from A/J mice. In hearts from male
C57BL/6J.YA/J and C57BL/6J mice, orchidectomy (ORX) affected in a strictly strain-specific fashion the expression a
subset of genes showing enrichment for functional categories, including that of circadian rhythms and cardiac
contractility. We further tested whether: (1) there were strain-specific differences in cardiac circadian rhythms; (2)
strain-dependent differences in the effects of ORX on contractility genes translated into differences in cardiac
functions; and (3) differential contractility responses occurred preferentially at times when circadian rhythms also
showed strain-specific differences.
Methods: In hearts from the two above strains, we (1) profiled the expression levels of 15 circadian genes at 4-h
intervals across a 24 h period; (2) tested the effects of either ORX or androgen replacement on expression of
cardiac contractility genes, and that of ORX on myocardial functional reserve; and (3) verified whether the effects of
MSY variants on cardiac contractility-related responses showed synchronicity with differences in circadian rhythms.
Results: Among the 15 tested circadian genes, a subset of them were affected by strain (and thus the genetic
origin of MSY), which interacted with the amplitude of their peak of maximal expression at 2:00 PM. At that same
time-point, ORX decreased (and androgen supplementation increased) the expression of three contractility-related
genes, and decreased myocardial relaxation reserve in C57BL/6J.YA/J, but not in C57BL/6J mice. These effects were
not detected at 10:00 AM, i.e., at another time-point when circadian genes showed no strain-specific differences.
Conclusions: The results indicate that in mice, androgens have activational effects on cardiac circadian rhythms,
contractile gene expression, and myocardial functional reserve. All effects occurred preferentially at the same time
of the day, but varied as a function of the genetic origin of MSY. Androgens may therefore be necessary but not
sufficient to impart male-specific characteristics to some particular cardiac functions, with genetic material from
MSY being one other necessary factor to fully define their range of actions.
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Background
Male-specific characteristics are defined by the actions of
androgens (gonadal sex) as well as that of the male-specific
portion of chromosome Y (MSY) (chromosomal sex). Al-
though androgens are responsible for many aspects of male
differentiation and keep contributing after puberty to many
male-specific phenotypes [1, 2], there is emerging evidence
that MSY has actions that can be distinguished from that of
gonadal steroids [3]. Another manner whereby MSY may
affect male-specific characteristics is (as shown previously in
rats [4] or mice [5, 6]) via modulation of the effects of andro-
gens, and thus by a mechanism that involves combined
actions of both gonadal and chromosomal sex. The clinical
importance of these mechanisms relates to the fact that most
common diseases display sex-specific differences, with the
male sex showing increased cardiovascular risk and vulner-
ability to related disorders [7, 8]. However, the roles played
by androgens in sex-specific cardiovascular differences are
not entirely clear, since previous studies showed discrepan-
cies and even sometimes contradictory results [9, 10].
MSY, in addition to possibly having basal effects that
manifest themselves in all males, also harbors genetic vari-
ants which contribute to phenotypic diversity in traits as
varied as cardiovascular functions, immune cell properties,
or cancer susceptibility [11, 12]. If genetic MSY variants
were to differ in their ability to modulate the effects of an-
drogens, this chromosome might constitute a source of
male-specific genetic factors that explain in part why the
effects of androgens are not uniform across individuals.
However, our understanding of the specific contributions
of variants MSY genetic variants has been limited in part
by the fact that MSY has structural and functional charac-
teristics that make this chromosomal segment difficult to
analyze by genetic techniques that are otherwise standard
for other chromosomes [11]. One useful model in this re-
gard has been that constituted by so-called “chromosome-
substituted” or “consomic” strains. Among available mouse
models, we have previously used the C57BL/6J.YA/J/NaJ
strain (corresponding to C57BL/6J mice in which the ori-
ginal MSY has been substituted for that from A/J mice) for
comparisons with the host C57BL/6J strain. These two
strains originate from a panel comprising a total of 22
mouse strains, each of which carrying a single chromo-
some substituted from the donor A/J strain onto a com-
mon host C57BL/6J background [13]. Our comparative
studies revealed that (1) cardiomyocytes from adult
C57BL/6 J.YA/J/NaJ hearts were smaller than that from their
C57BL/6 J counterparts [14]; (2) orchidectomy (ORX)
decreased the size of cardiomyocytes from adult
C57BL/6J mice, but not that from their C57BL/6 J.YA/J/NaJ
counterparts; and (3) ORX decreased in adult male
C57BL/6 J.YA/J/Naj mice (but not in their C57BL/6J
counterparts) the expression of phospholamban (Pln), titin
(Ttn) and “four and a half LIM domains 2” (Fhl2), i.e.,
three genes closely related to cardiac contractility, relax-
ation, and performance [6].
In addition to cardiac contractility, another category that
was enriched within genes showing MSY-dependency in
their responses to ORX was that of the circadian rhythm
signaling pathway [5]. Rhythmic oscillations of circadian
genes occur in virtually all organs and tissues, and play im-
portant roles in health and disease [15]. Interestingly, circa-
dian rhythms also exhibit sex-related differences [16–18]. In
both male and female rodents, gonadal steroids modify the
amplitude, free-running period and phase of daily rhythms
[17, 19, 20]. In particular, androgens play major roles in the
regulation of the suprachiasmatic nucleus, which synchro-
nizes the phase of clocks throughout the body [16, 21]. In
hearts, circadian cycles have important functional conse-
quences: (1) in naturally cycling animals, they affect both
myocardial metabolism and contractile functions in a co-
ordinate fashion [22], and (2) genetic manipulations that in-
hibit circadian regulation (either at the whole body level or
in a cardiomyocyte-specific fashion) have deleterious effects
on cardiac functions, metabolism and signaling properties,
and associate with a marked reduction in lifespan [23–25].
To extend our previous studies (which were performed
at only one particular time of the day), we compared the
expression of circadian genes in hearts of male mice
from both strains (either intact or ORX) at 4-h intervals
across a 24-h period. Likewise, to verify whether differ-
ences in the effects of androgens on cardiac contractility
genes translated into functional differences, we compared
the effects of either androgen withdrawal or supplementa-
tion in hearts from C57BL/6J and C57BL/6J.YA/J/NaJ male
mice. In particular, we tested for potential differences in
the effect of androgens on myocardial functional reserve,
i.e., a function that is mostly affected by differences in
sarcoplasmic reticulum Ca2+, which is itself tightly reg-
ulated by Pln [26]. Since contractility, circadian rhythms
and MSY variants may all show interdependent relation-
ships, we tested whether the effects of MSY variants on car-
diac functional responses occurred in synchronicity with
differential effects on circadian rhythms. We found that the
effects of MSY variants on cardiac expression of contractil-
ity genes were accompanied by differences in myocardial
functional reserve, with all effects occurring preferentially
at time-points when circadian genes also showed strain-
specific differences. These results, in addition to showing
the multiple ways whereby MSY genetic variants may affect
cardiac functions, also imply that the activational effects of
androgens on some cardiac functions depend in part on
the particular genetic makeup of MSY in male mice.
Methods
Animals
Male founders for the C57BL/6J and the C57BL/6J.chrYA/J
strains (the latter being simply designated C57.YA/J further
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in the manuscript) were obtained from The Jackson La-
boratory. The strains have been maintained for more than
8 years at the mouse facility of the Institut de recherches
cliniques de Montréal (IRCM) by crossing either C57BL/6J
or C57BL/6J.chrYA/J males with C57BL/6J females. To
minimize the possible occurrence and/or maintenance
of de novo autosomal variants within the colony, mothers
were replaced regularly with females from the original ref-
erence genetic stock (obtained from The Jackson Labora-
tory). Consistent genetic differences between the two
strains were thus restricted to just MSY polymorphisms,
whose persistence was verified periodically by PCR ampli-
fication and sequencing of the genomic region surround-
ing the MSY rs47889323 single nucleotide polymorphism
in animals from each strain, as described previously [6].
All mice were maintained in an animal facility with
lights on at 6:00 AM and off at 6:00 PM. All comparisons
were made in 12-week-old animals. When ORX mice were
needed, surgery was performed at 3 weeks of age in order
to prevent the rise of testosterone that normally occurs at
puberty, as described previously [5]. Hormonal replace-
ment in ORX animals was performed by subcutaneous im-
plantation of 10-mm-long SILASTIC brand tubing (id,
1.47 mm; od, 1.96 mm; Dow Corning) filled with crystal-
line 5α-dihydrotestosterone (DHT; Steraloids, Newport,
RI) and sealed with silicone 732 Dow Corning rubber glue,
as described previously [27]. Implantation was performed
in 9-week-old ORX animals, and the animals were killed
3 weeks after the day of implantation. Control animals
were implanted with empty SILASTIC tubes of equivalent
length. For studies on circadian rhythms, times of the day
were defined as “Zeitgeber times”, (ZT), with ZT0 corre-
sponding to 6:00 AM, ZT4 corresponding to 10:00 AM,
etc. Starting from ZT0, groups of animals (n = 4) were
killed at 4-h intervals. During experimental times at night,
the animal room was illuminated with red light only.
Gene expression
Total RNA was extracted from the left ventricular samples
and gene expression was monitored by using reverse tran-
scription quantitative polymerase chain reaction (RT-qPCR)
to calculate the values of relative expression vs. that of the
normalizing Rps16 housekeeping gene, as described
previously [6]. We monitored the expression levels of a
total of 15 circadian genes belonging to the following
groups: (1) the main circadian clock transcriptional activa-
tors (Bmal1/Arntl, Clock and its Npas paralog); (2) the
main circadian clock transcriptional repressors (Per1, Per2,
Per3, Cry1, and Cry2); (3) output genes acting as transcrip-
tional activators and belonging to either the proline and
acidic amino-acid-rich basic leucine zipper (PAR bZIP)
family (Dbp, Tef, and Hlf) or the retinoic acid related or-
phan receptor (ROR) family (Rora); and (4) output genes
acting as transcriptional repressors, i.e., two Rev-Erb genes
(Nr1d1 and Nr1d2) and the E4bp4/Nfil3 gene, which be-
longs to the bZIP family. The composition of each pair
of primers is as listed (Additional file 1: Table S1).
Hemodynamic functional studies
Myocardial functional reserve for either contraction or re-
laxation was measured in 12-week-old animals as described
previously [28]. The mice were anesthetized by intraperito-
neal injection of ketamine (100 mg/kg) and xylazine (5 mg/
kg), intubated and ventilated, and placed in supine position
on a heating pad. A 1.2 F Millar pressure catheter was
inserted in the right carotid and pushed into the left ventri-
cles. A central venous line was put in place by inserting into
the left jugular vein a PE-10 tubing filled with heparinized
saline and connected to a Hamilton syringe. Left ventricular
pressure recordings were acquired using a PowerLab/8 SP
acquisition system (ADInstruments; Colorado Springs, CO)
and combined with electrocardiography signals. After base-
line measurements, the saline solution was replaced with
one containing dobutamine 50 ng/μl. Administration of do-
butamine (1 ng/g/min) was performed by infusing the
dopamine solution at a rate of 20 nl/g/min for 4 min,
followed by 2 min infusion steps delivering 40, 100, and
200 nl/g/min (i.e., 2, 5 and 10 ng/g/min). Data were ana-
lyzed with the Chart for Windows analysis software (ADIn-
struments). The rates of contraction and relaxation were
assessed by recording maximal positive (dP/dt max) and
minimal negative (dP/dt min) pressure developments at the
end of each incremental infusion step, with the slope of
their dose-related changes being used to assess myocardial
functional reverse.
Statistics
The significance of interactions between the effects of strain
with that of either time or surgery were calculated by
two-way ANOVA, using Prism 7 for Windows (Graph-
Pad Software). Intergroup differences were calculated using
post-hoc Tukey tests. Some differences involving only two
groups were performed using t tests.
Results
Strain-dependent differences in cardiac expression of
circadian genes
Across the 24-h period, some circadian genes showed
suggestive differences in genes expression, all of them
occurring mostly at ZT8 (Fig. 1). For the genes showing
the greatest strain-dependent differences, the results of
two-way ANOVA analyses of the interactions of strain with
time were as follows: Dbp (P = 0.0148, F = 3.1, η2 = 0.043),
Tef (P = 0.007, F = 3.57, η2 = 0.089), and Nr1d2 (P = 0.015,
F = 3.10, η2 = 0.098), with dfn = 6 and dfd = 36 for all
groups. None of these interaction terms reached signifi-
cance when using a Bonferroni-corrected P value of 0.003
(i.e., 0.05/15 to correct for the 15 two-way ANOVAs).
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Nonetheless, we considered the fact that all differences oc-
curred at the same ZT8 time-point to be suggestive, and
thus performed a replication experiment with new experi-
mental animals (one full year after the initial experiment).
The design of the experiment was also changed in the fol-
lowing manner: (1) a larger number of animals (n = 7–8)
were used at each time-point; (2) since the previous analysis
revealed strain-dependent differences occurred only around
ZT8, we restricted our analysis to the daytime points (ZT
0, 4, 8, and 12); and (3) we analyzed only Dbp, Tef and Hlf
genes, since the greatest differences were previously ob-
served for the first two genes, and all three correspond to
functionally redundant genes that belonged to the same
PAR bZIP family [29]. Time (but not strain) had a signifi-
cant overall effect on expression of all three genes. How-
ever, the values of the strain × time interactions were as
follows: Dbp (P = 0.0058, F = 4.68, η2 = 0.04), Tef (P = 0.014,
F = 3.34, η2 = 0.09), and Hlf (P = 0.033, F = 3.16, η2 = 0.077),
with dfn = 3 and dfd = 50 for all groups (Fig. 2). Using a
Bonferroni-corrected P value of 0.016 (i.e., 0.05/3 to correct
for the three two-way ANOVAs), these interactions reached
significance for Dbp and Tef. Of note, these results were
very similar to those obtained in the first experiment, with
(1) differences being observed at ZT8, and (2) the values
of the time × strain interactions being higher for Dbp and
Tef than for Hlf. Finally, to test whether the strain-
dependent differences were also androgen-dependent,
the same experiment with ORX animals was repeated.
In the absence of endogenous androgens, interactions
of strain with time were no longer observed (Additional
file 2: Figure S1).
Androgen-dependency of expression of contractility-
related genes in hearts of C57.YA/J male mice at ZT8
We tested the effects of ORX on expression of Pln, Ttn
and Fhl2 in hearts of animals killed at ZT8, i.e., at the
same time when strain-dependent differences were de-
tected for circadian genes. ORX reduced expression of
all three genes in C57.YA/J mice, but not in that of their
C57BL/6J counterparts. Accordingly, there was a signifi-
cant interaction of the effect of surgery with that of
strain for Pln (P = 0.027, F = 5.32, η2 = 0.098), Ttn (P =
0.026, F = 5.35, η2 = 0.086), and Fhl2 (P = 0.038, F = 4.64,
η2 = 0.237), with dfn = 1 and dfd = 35 for all groups (Fig. 3).
In reverse, we also detected a significant interaction of strain
with the effect of DHT treatment, with the latter increasing
Pln expression in hearts from C57.YA/J mice, but not in that
of their C57BL/6J counterparts (P= 0.024, F = 5.98, η2 =
0.19, dfn = 1, dfd = 20). Although the interaction between
strain and treatment was not significant by two-way
ANOVA for Fhl2 and Ttn, t tests revealed that DHT in-
creased expression of these two genes in ORX in C57.YA/J
mice, and that the effect was either less significant (for Fhl2)
or not detected (for Ttn) in C57BL/6J mice (Fig. 3). In
Fig. 1 Profiling of expression of 15 circadian genes in hearts from intact C57BL/6J and C57.YA/J male mice. Expression levels were measured at 4-
h intervals between ZT0 and ZT20. Values at each time-point correspond to mean ± SEM (n = 4). The arrows point to ZT8, which is a time when
several circadian genes show some disparity in expression levels. Post-hoc Tukey multiple comparison tests were performed for the three genes
where the significance of the strain × time interaction had a P value <0.05 (*P < 0.05; **P < 0.01)
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animals killed at ZT4, no strain-dependent difference
in gene expression was detected across the experimen-
tal groups (Additional file 3: Figure S2).
Strain-specific differences in myocardial functional
reserve at ZT8
Reduced abundance of PlnmRNA typically associates with
a reduced sarcoplasmic reticulum Ca2+ load [26]. This in
turn causes an impairment of myocardial functional re-
serve, an effect that can be monitored by testing the effects
of adrenergic stimulation on cardiac contractility [30, 31].
Dobutamine increased the rates of both contraction and
relaxation in a dose-relation fashion, with the magnitude
of responses corresponding to myocardial inotropic and
lusitropic reserve, respectively. When using doses ranging
from 0 to 10 ng/kg/min, we observed that the values of
dP/dt max and dP/dt min increased and decreased, re-
spectively, in a linear fashion (Additional file 4: Figure S3).
Accordingly, we expressed inotropic reserve as the differ-
ence in dP/dt max at the maximal dose of dobutamine vs.
Fig. 2 Profiling of expression of Dbp, Tef, and Hlf in hearts from sham-operated C57BL/6J and C57.YA/J male mice. Expression levels were measured at
4-h intervals between ZT0 and ZT12. Values at each time-point correspond to mean ± SEM (n = 7–8). P values for each term of the two-way ANOVA
analysis are as indicated. The asterisks correspond to the significance of the differences detected by post-hoc Tukey multiple comparison
tests (**P < 0.01). The P values for all terms of the two-way ANOVA tests are as indicated
Fig. 3 Effects of either surgery (a–c) or of chronic treatment with DHT (d–f) on expression levels of Pln, Ttn, and Fhl2 in hearts from C57BL/6J and
C57.YA/J male mice. Values at each time-point correspond to mean ± SD (n = 6–8). P values correspond to those for the interaction of strain with
the effect of surgery. The asterisks (a–d) correspond to the significance of the differences detected by post-hoc Tukey multiple comparison tests
(*P < 0.05; **P < 0.01; ***P < 0.001). e, f Significance of differences as detected by t tests between animals implanted with either empty (VEH) or
DHT-filled (DHT) silastic tubes (*P < 0.05; ***P < 0.001)
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that recorded at baseline, and lusitropic reserve as the dif-
ference in dP/dt min at baseline vs. that recorded with the
maximal dose of dobutamine. Inotropic reserve was signifi-
cantly higher in C57BL/6J male mice than their C57.YA/J
counterparts (both in sham-operated and ORX animals),
but strain did not interact with the effect of ORX (Fig. 4).
In contrast, ORX greatly decreased lusitropic reserve in
C57.YA/J male mice, but not in their C57BL/6J counter-
parts, causing a significant interaction of strain with the ef-
fect of surgery (P = 0.043, F = 4.65, η2 = 0.069). Myocardial
functional reserve was not affected by either strain or sur-
gery in animals tested at ZT4 (Additional file 5: Figure S4).
Discussion
Circadian rhythms, which occur in virtually all organs and
tissues, display sex-related differences [16–18] and are af-
fected by gonadal steroids in both male and female rodents.
Sex steroids may shape circadian rhythms by acting at
several levels and via different mechanisms. Their effects
may involve either “organizational” effects (occurring in
early development and during puberty) or non-permanent
“activational” effects during adulthood [32–34]. One par-
ticular study reported that, although the activational effects
of gonadal hormones could account for the majority of
sex-specific differences in circadian activity, sex chromo-
some complement could nonetheless play a minor role by
affecting the duration of circadian activity bouts [34]. In
the current study, we found that ORX affected the peak
amplitude of maximal expression of Dbp and Tef at
2:00 PM in male C57BL/6J mice, but not in their C57.YA/J
counterparts. One possible interpretation of the results is
that the increase of expression of Dbp and Tef that natur-
ally occurs at ZT8 is amplified by physiological levels of an-
drogens in C57BL/6J male mice, but not in their C57.YA/J
counterparts. Dbp and Tef both belong (along with Hlf,
whose expression was affected in a similar although non-
significant manner) to the PAR bZIP family. They have
been reported to be functionally redundant and appear to
have cardioprotective properties, as simultaneous deletion
of all three leads to the development of cardiac hypertrophy
and left ventricular dysfunction [29].
To extend our previous data showing that contractility-
related genes were affected by ORX in hearts from
C57.YA/J male mice but not in that of their C57BL/6J
counterparts, we further tested whether (1) DHT supple-
mentation affected the expression of these genes in a simi-
lar strain-specific fashion and (2) differences in gene
expression translated into differences in cardiac functions.
These experiments were first performed at ZT8, i.e., at the
time when MSY variants were found to affect expression
of circadian genes. ORX and DHT supplementation de-
creased and increased, respectively, the expression the ex-
pression of Pln, Ttn, and Fhl2 in hearts of male C57.YA/J
mice, but not in that of their C57BL/6J counterparts. The
ORX-dependent decrease in the expression of these genes
appeared to be functionally important, since ORX also de-
creased myocardial lusitropic reserve in the same strain-
specific fashion. Myocardial functional reserve is mostly
affected by differences in sarcoplasmic reticulum Ca2+ [30,
31], which is itself tightly regulated by Pln and other Ca2+
regulatory proteins [26]. Likewise, Ttn is a strong modula-
tor of muscle force [35], while Fhl2 is a regulator of car-
diac contractility that also protects the heart against
adrenergic stress [36].
The negative effects of ORX on the performance of
C57.YA/J hearts are generally compatible with the intui-
tive consensus that androgens increase cardiac perform-
ance. Although generally true, this concept is supported
by only a limited number of animal studies, all of which
have been performed in rats. In that species, ORX causes
a significant suppression of both contractile and relaxation
activities of either isolated hearts [37, 38], myocardial
trabeculae [39] or cardiomyocytes [40, 41], with the effects
being reversed by testosterone replacement. Interestingly,
Fig. 4 Effects of surgery on myocardial inotropic (left) and lusitropic (right) reserves. All measurements were performed at ZT8; values are mean ±
SD (n = 6–8). Left: only strain had a significant effect; the asterisks correspond to the significance of differences as detected by post-hoc Tukey multiple
comparison tests (***P < 0.001; **P < 0.01). Right: there was a significant interaction of strain with the effect of surgery on lusitropic reserve. The asterisks
correspond to the significance of the differences detected by post-hoc Tukey multiple comparison tests (**P < 0.01)
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some reported that while androgens did not always affect
basal contractility, they could affect (similarly as found in
the current study) myocardial functional reserve [42, 43]. In
addition to constituting a useful index that can detect subtle
differences in cardiac performance in either humans [30] or
animal models [44], cardiac functional reserve also provides
dynamic information by measuring the responses of the
heart to more challenging conditions [43]. Our data show-
ing that ORX decreases both Pln and myocardial functional
reserve are also compatible with reports that (1) ORX de-
creases the amplitude of Ca2+ transients and prolongs the
time course of Ca2+ transient decay, with the effects being
reversed by testosterone replacement [41] and (2) andro-
gens increase the expression and/or activity of several Ca2+
regulatory proteins that play a predominant role in myocar-
dial contraction and relaxation cycles [26, 39, 42, 45].
Although ORX affected both the expression of contract-
ility genes and myocardial functional reserve in C57.YA/J
hearts at ZT8, no such effects were observed at ZT4, i.e.,
at a time when cardiac circadian genes showed no strain-
dependent differences. We did not demonstrate that the
strain-specific effects of ORX on myocardial reserve were
a direct consequence of corresponding differences in car-
diac circadian gene expression. Of note, it was in C56BL/
6J mice where ORX had strain-specific effects on the amp-
litude of circadian gene expression and (as shown previ-
ously [5]) on the size of cardiomyocytes, whereas it was in
C57.YA/J that ORX had strain-specific effects on the ex-
pression of contractility genes and myocardial functional
reserve. Nonetheless, what is common in all strains is that
all effects were detected at ZT8, which may represent a
preferential time when MSY variants may affect cardiac
functions. This particular time is of particular interest from
a cardiovascular stand-point. The sleep-to-wake transition
represents a critical time when the heart needs to prepare
for changes in energy demands. In humans, the onset of
cardiac pathologic events peaks shortly before that time
[22]. Mice are nocturnal animals, with their sleep-to-wake
transition occurring at ZT12. Interestingly, mouse hearts
subjected to ischemia/reperfusion showed greater infarct
volume, adverse remodeling and depression of contractile
function when the injury was inflicted at ZT12 rather than
at ZT0 [46]. We found that MSY variants affected circa-
dian genes expression primarily at ZT8, i.e., the last time-
point preceding the critical sleep-to-wake transition. At
the very least, the results indicate that (1) the effects of an-
drogens on cardiac performance do not only depend on
the genetic make-up of MSY, but that they may also vary
in importance at different times across the circadian cycle,
and (2) the latter two factors may constitute sources of
variance for some of the physiologic effects of androgens.
One implication of our results is that male-specific char-
acteristics of mouse hearts are not shaped by androgens
only, but that the effects of the latter also depend on
interactions with genetic factors carried by MSY. In rats, it
has previously been reported that the effects of MSY vari-
ants on blood pressure required the presence of androgen
receptors [4] and corresponded to variant-specific interac-
tions of the “sex-determining region on chrY” (Sry) gene
with androgen receptors [47]. However, rats represent a par-
ticular case in terms of MSY genetics because, unlike other
vertebrates, it carries 11 copies of Sry [47], some of which
harbor functional mutations that alter either their temporal
expression across tissues or their cellular functions. For in-
stance, the rat genome contains the Sry2 isoform whose ex-
pression is maintained in all tissues and persists during
adult life. Likewise, the interaction of Sry with the transcrip-
tional activity of androgen receptors depends on a proline
to threonine substitution in the rat-specific Sry3 [47].
Humans carry only one SRY copy, with its expression being
maintained in a limited set of tissues during adult life [11].
Although human SRY interacts with some transcriptional
activities of androgens, such interactions have been shown
only in the context of prostatic cells [48].
In mice, there is a very tight spatio-temporal control that
limits the expression of Srymostly to the precursors of Ser-
toli cells and at very restricted times during development
[49]. We ourselves failed to detect any expression of Sry in
several mouse adult tissues, including hearts (data not
shown). In mice (where it is thus unlikely that the interac-
tions of MSY variants with the effects of androgens involve
Sry), the exact nature of causal genomic variants thus re-
mains to be identified. Only four MSY protein-coding
genes (Uty, Eif2s3y, Kdm5d, and Ddx3y) are expressed out-
side of testes in mice [50]. Although we showed previously
that expression of Uty and Kdm5d was higher in hearts
from C57BL/6J mice than in that from their C57.YA/J
counterparts, these differences were observed only in
newly born pups [6]. Nonetheless, such perinatal differ-
ences may affect the “organizational” effects of androgens,
which themselves may have effects that persist until adult-
hood. Beyond gene expression, it also remains to be deter-
mined to which extent differences in the expression of
these genes are matched by differences in the abundance
of cognate proteins. For instance, despite being expressed
ubiquitously, the Ddx3y mRNA transcript is not translated
outside of germ cells [51]. One other possibility to consider
is that MSY variants may associate with differences in ex-
pression of non-protein coding genes (including long non-
coding or micro RNAs), although no such genes have been
reported yet as originating from mouse MSY. Finally, a full
sequence of mouse MSY is currently available for only one
strain [52]. More work is therefore needed to determine
the exact nature of polymorphisms responsible for the dif-
ferential effects of MSY variants in mice.
Although it is well accepted that male sex associates with
increased cardiovascular mortality, the effects of androgens
themselves are more controversial. On one hand, low
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endogenous bioavailable testosterone levels associate with
higher cardiovascular-related mortality, suggesting that an-
drogens may be cardioprotective [9]. On the other hand,
while testosterone therapy may have some beneficial car-
diac effects, a meta-analysis of placebo-controlled random-
ized trials also showed that it increased cardiovascular-
related events among men [53]. Some have suggested the
increased cardiovascular risk in males might relate to fac-
tors other than androgens themselves, such as androgen re-
ceptor coregulators or determinants of androgen sensitivity
[10]. Interestingly, we showed previously that MSY variants
associate with differences in the abundance of androgen re-
ceptors in the vicinity of genes showing differential re-
sponses to ORX [6]. This provides a potential mechanism
whereby MSY can govern the sensitivity of particular genes
to androgens via changes in chromatin architecture. More-
over, MSY might be considered as a source of male-specific
genetic factors explaining in part why the effects of andro-
gens vary across individuals. A better understanding of how
MSY variants modulate the effects of androgens and which
genes are responsible for such effects may improve our as-
sessment of male-specific risk by helping to predict whether
androgens will have either positive or negative effects in
particular individuals, or to identify which ones are most
likely to be either affected negatively by declines in testos-
terone and/or benefit from androgen supplementation.
Conclusions
Although androgens are necessary to impart male-specific
characteristics to cardiac functions, they may not be suffi-
cient to shape some of such functions, with the con-
comitant presence of genetic factors carried by MSY
being required to fully define the range of their effects.
Moreover, genetic variants of MSY vary in their ability to
modulate the activational effects of androgens. Their ef-
fects are sufficiently important to have an impact on car-
diac functions, and may possibly explain some lack of
consistency in previously published concerning the effects
of androgens on the heart.
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